William F Novotny

Title: The Innovations of William F. Novotny

Introduction

William F. Novotny is a notable inventor based in Menlo Park, California. He has made significant contributions to the field of molecular biology and cancer treatment. With a total of four patents to his name, Novotny's work focuses on innovative solutions for diagnosing and treating prostate cancer.

Latest Patents

Among his latest patents is a gene expression profile algorithm and test for determining the prognosis of prostate cancer. This invention provides algorithm-based molecular assays that involve measuring expression levels of genes, or their co-expressed genes, from biological samples obtained from prostate cancer patients. The genes may be grouped into functional gene subsets for calculating a quantitative score useful to predict the likelihood of a clinical outcome for a prostate cancer patient. Another significant patent involves treatment with anti-VEGF antibodies. This invention concerns the treatment of diseases and pathological conditions with anti-VEGF antibodies, specifically targeting human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.

Career Highlights

Throughout his career, Novotny has worked with prominent companies such as Genentech, Inc. and Genomic Health, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of cancer research and treatment.

Collaborations

Some of his notable coworkers include Gwendolyn Fyfe and Eric Holmgren. Their collaborative efforts have contributed to the advancement of research in molecular biology and cancer therapies.

Conclusion

William F. Novotny's contributions to the field of cancer research through his patents and collaborations highlight his commitment to improving patient outcomes. His innovative approaches continue to influence the landscape of cancer diagnostics and treatment.